VERA
Vera Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.92
+3.73%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$1.61
- Revenue estimate
- $3.9M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$1.52
- EPS estimate
- -$1.58
- Revenue actual
- —
- Revenue estimate
- $1.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.8%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $60
- PT range
- $34 – $90
- Analysts
- 4
2 Buy2 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$1.58 | -$1.52 | Beat 3.80% | — |
| May 7, 2026 | -$1.33 | -$1.69 | Miss -27.22% | — |
| Nov 5, 2025 | -$1.20 | -$1.26 | Miss -5.00% | — |
| Feb 26, 2025 | -$0.83 | -$0.72 | Beat 13.25% | — |
| Nov 7, 2024 | -$0.69 | -$0.85 | Miss -23.19% | — |
| Aug 8, 2024 | -$0.58 | -$0.62 | Miss -6.90% | — |
| May 9, 2024 | -$0.53 | -$0.56 | Miss -5.66% | — |
| Mar 20, 2024 | -$0.53 | -$0.58 | Miss -9.43% | — |
| Nov 9, 2023 | -$0.50 | -$0.45 | Beat 10.00% | — |
| Aug 10, 2023 | -$0.69 | -$0.46 | Beat 33.33% | — |
| May 11, 2023 | -$0.60 | -$0.80 | Miss -33.33% | — |
| Nov 9, 2022 | -$0.72 | -$0.91 | Miss -26.39% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026